Precio FOB
Obtener el precio más reciente2 ~ 3 / Unit
|500 Unit Minimum Order
País:
USA
N º de Modelo:
-
Precio FOB:
2 ~ 3 / Unit Obtener el precio más reciente
Lugar de origen:
-
Precio de pedido mínimo:
2 per Unit
Cantidad de pedido mínimo:
500 Unit
Detalle de embalaje:
-
El tiempo de entrega:
-
Capacidad de suministro:
-
Tipo de pago:
-
Grupo de productos :
-
Persona de contacto Mr. Orchard W
100 N Howard ST STE R, Spokane, Washington 99201, USA, USA, Los Angeles, California
Pfizer-BioNTech COVID**9 Vaccine is authorized for emergency use and is available under the EUA as a two-dose primary series for individuals 5 years of age and older, as a third primary series dose for individuals 5 years of age and older who have been determined to have certain kinds of immunocompromise, and as a single booster dose for individuals *2 years of age and older at least five months after completing a primary series of the vaccine.
The Pfizer-BioNTech COVID**9 Vaccine is also authorized for use as a heterologous (or mix and match) single booster dose for individuals *8 years of age and older following completion of primary vaccination with a different available COVID**9 vaccine. For example, Moderna and Janssen COVID**9 vaccine recipients *8 years of age and older may receive a single booster dose of the Pfizer-BioNTech COVID**9 Vaccine.
On February *1, ***2, in consultation with FDA, CDC updated the emergency use instructions to provide information about the primary, additional, and booster doses of the Pfizer COVID**9 vaccines in certain individuals.
| País: | USA |
| N º de Modelo: | - |
| Precio FOB: | 2 ~ 3 / Unit Obtener el precio más reciente |
| Lugar de origen: | - |
| Precio de pedido mínimo: | 2 per Unit |
| Cantidad de pedido mínimo: | 500 Unit |
| Detalle de embalaje: | - |
| El tiempo de entrega: | - |
| Capacidad de suministro: | - |
| Tipo de pago: | - |
| Grupo de productos : | - |
